“…Additionally, some control patients have rapid recovery of tuberculosisspecific T-cell function similar to TB-IRIS patients, but do not progress to IRIS [15][16][17]. In an exploratory analysis, we tested the hypothesis that increases in IL-6 levels, which have been associated with IRIS [11,13,15,20], would be less in control patients who also had rapid recovery of cellular immune function compared to TB-IRIS patients using previously determined IL-6 concentrations [15] and rank-sum tests. In this analysis, controls were restricted to those described in this study who had increases at week 4 of ART that were greater than the overall group median for IFN-γ + /IL-2 + /TNF-α + CD4 + T-cells, CD4 cell counts, and tuberculosis-specific IFN-γ responses by enzyme-linked immunospot (ELISpot) assay [15].…”